Latest news with #SLAS2025
Time of India
31-07-2025
- Politics
- Time of India
‘Chennai must improve performance to be among top 10 districts'
Chennai: The govt schools in Chennai district need to improve their performance to be among the top 10 districts in the state, school education minister Anbil Mahesh Poyyamozhi said here on Thursday. Speaking at the review meeting for improving the learning outcomes of govt schools in Chennai, Poyyamozhi said the education blocks, including Tiruvottiyur, Kodambakkam, and Royapuram (north), have done well at the state level achievement survey (SLAS) conducted for students studying in Classes III, V, and VIII. The students from govt schools in Chennai in Classes III, V, and VIII performed below the state average, according to the SLAS 2025. Further, the district also performed poorly in board exams, ranking among the bottom five districts in pass percentage this year. "According to the SLAS 2025 report, the schools from educational blocks, including Adyar, Tandiarpet, Royapuram (South), Teynampet, and Royapuram (central) need improvement, while schools in Anna Nagar and Thiru Vi Ka Nagar need to focus more," Poyyamozhi said. "Further, the SLAS, which was conducted among 9.8 lakh students throughout the state, has provided a progress report for each school. District institutes of education and training (DIETs) have prepared a specific action plan for each district. Headmasters can customise the plan based on the needs of individual schools," he added. You Can Also Check: Chennai AQI | Weather in Chennai | Bank Holidays in Chennai | Public Holidays in Chennai
Associated Press
27-01-2025
- Business
- Associated Press
Sphere Fluidics Launches Cyto-Mine Chroma and Announces Early Access Program
CAMBRIDGE, England--(BUSINESS WIRE)--Jan 27, 2025-- Sphere Fluidics, a leading provider of innovative picodroplet-based microfluidics solutions for functional single cell analysis and isolation, today announced the launch of Cyto-Mine ® Chroma and the opening of its Early Access Program at SLAS2025 International Conference and Exhibition in San Diego. Cyto-Mine Chroma represents the next generation of Sphere Fluidics' industry-leading Cyto-Mine single-cell analysis platform. The Early Access Program provides an opportunity to be among the first to demo the Cyto-Mine Chroma for faster project timeline completion and improved outcomes across broad applications, including antibody discovery, cell line development, and emerging areas such as cell therapy. Through the program, the Company will collaborate closely with forward-thinking customers to drive innovation and inform the development of future applications and assays on the platform. Offering enhanced capabilities, including multiplexing and greater assay flexibility, Cyto-Mine Chroma has been developed to maximize the efficiency and precision of single-cell functional analysis – enabling tens of millions of cells to be screened in a day. Leveraging a four-color laser and detector system, Cyto-Mine Chroma expands the number of parameters that can be analyzed for each cell in a single assay. This supports the upcoming launch of the Company's first multiplexed assay kit, facilitating multiple readouts within a single experiment, optimizing the throughput and precision of cell selection. By accelerating the early selection of superior candidate cells for downstream expansion or further analysis, overall timelines are reduced from months to weeks, while reducing effort and cost. Sphere Fluidics will be showcasing Cyto-Mine Chroma at its booth (#2744) at SLAS2025. Chief Technology Officer, Richard Hammond, will be presenting a Solutions Spotlight demonstrating the new platform's capabilities on day two of the conference, Tuesday January 28 th, 12:00 – 12:20pm. 'The next-generation Cyto-Mine Chroma platform has been designed to transform single-cell analysis. We are excited to unveil this innovative platform and its Early Access Program at SLAS, the premier event for lab automation and screening. This launch underscores our dedication to advancing biotechnology. Collaborating closely with key industry stakeholders and researchers will allow us to ensure our microfluidic technologies meet the evolving needs of the sector, both now and in the future.' commented Dale Levitzke, CEO, Sphere Fluidics. CONTACT: For further information please contact: Dr Claire Cox Sphere Fluidics Ltd. Tel: +44 (0)7365 209 441 Zyme Communications Lily Jeffery KEYWORD: UNITED KINGDOM EUROPE SOURCE: Sphere Fluidics Copyright Business Wire 2025. PUB: 01/27/2025 04:22 AM/DISC: 01/27/2025 04:22 AM
